The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? (Q38049252)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034604%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034604%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

9 March 2020

main subject

feces

0 references

0 references

microbiome

0 references

author name string

Christopher J Damman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034604%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Timothy L Zisman

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034604%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

English

0 references

publication date

1 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034604%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034604%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034604%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034604%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

1452-1459

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23034604%20AND%20SRC:MED&resulttype=core&format=json

The human microbiome project

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

The Human Microbiome Project in 2011 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Metagenomic analysis of the human distal gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Host-bacterial mutualism in the human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Diversity of the human intestinal microbial flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Obesity alters gut microbial ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

In search of an uncultured human-associated TM7 bacterium in the environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Towards the human intestinal microbiota phylogenetic core

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Enterotypes of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Linking long-term dietary patterns with gut microbial enterotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Unravelling the effects of the environment and host genotype on the gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Development of the human infant intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Shifting the balance: antibiotic effects on host-microbiota mutualism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Bacterial community variation in human body habitats across space and time

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Gut Microbiota in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

The role of the intestinal microbiota in the development of atopic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Human nutrition, the gut microbiome and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

The struggle within: microbial influences on colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Microbial induction of immunity, inflammation, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Current concepts of the intestinal microbiota and the pathogenesis of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Role of the microbiota in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Microbial influences in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Sequencing technologies - the next generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Diversity of the human gastrointestinal tract microbiota revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Experimental and analytical tools for studying the human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Creating and characterizing communities of human gut microbes in gnotobiotic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Identification of NF-κB modulation capabilities within human intestinal commensal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

The starting lineup: key microbial players in intestinal immunity and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

The human microbiome and infectious diseases: beyond koch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Family and twin studies in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Recent Insights Into the Genetics of Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

The genetics and immunopathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

An evidence-based systematic review on medical therapies for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Experimental inflammatory bowel disease: insights into the host-microbiota dialog

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Probiotics in the treatment of human inflammatory bowel diseases: update 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Rifaximin in the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Gastrointestinal infection as a trigger for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Induction of colonic regulatory T cells by indigenous Clostridium species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93

Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2012.93